The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Dec. 15, 2020
Filed:
Nov. 05, 2014
Applicant:
Optibiotix Limited, York, GB;
Inventor:
Stephen Patrick O'Hara, York, GB;
Assignee:
Optibiotix Limited, York, GB;
Attorneys:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A23L 33/16 (2016.01); A23L 33/135 (2016.01); A23L 33/21 (2016.01); A23L 33/125 (2016.01); A23C 9/127 (2006.01); A23C 9/20 (2006.01); A61K 31/733 (2006.01); A61K 31/702 (2006.01); A61K 31/736 (2006.01); A61K 33/24 (2019.01); A61K 35/741 (2015.01); A23L 29/244 (2016.01); A23L 33/00 (2016.01); A23L 33/15 (2016.01); A61K 45/06 (2006.01); A61K 9/48 (2006.01); A23C 9/123 (2006.01); A23C 9/13 (2006.01); A23C 9/133 (2006.01); A23C 9/137 (2006.01); A23C 17/02 (2006.01); A23C 19/06 (2006.01); A61K 35/744 (2015.01); A61K 35/747 (2015.01); A61K 35/00 (2006.01);
U.S. Cl.
CPC ...
A23L 33/135 (2016.08); A23C 9/1238 (2013.01); A23C 9/133 (2013.01); A23C 9/137 (2013.01); A23C 9/1307 (2013.01); A23C 9/1322 (2013.01); A23C 17/02 (2013.01); A23C 19/062 (2013.01); A23L 29/244 (2016.08); A23L 33/15 (2016.08); A23L 33/16 (2016.08); A23L 33/21 (2016.08); A23L 33/30 (2016.08); A23L 33/40 (2016.08); A61K 9/48 (2013.01); A61K 31/702 (2013.01); A61K 31/733 (2013.01); A61K 31/736 (2013.01); A61K 33/24 (2013.01); A61K 35/741 (2013.01); A61K 35/744 (2013.01); A61K 35/747 (2013.01); A61K 45/06 (2013.01); A23V 2002/00 (2013.01); A23Y 2220/15 (2013.01); A23Y 2220/29 (2013.01); A23Y 2240/75 (2013.01); A61K 2035/115 (2013.01);
Abstract
The present invention relates to compositions for weight management comprising: a) a microbiome modifying component; b) a satiety modifying component; and c) a metabolic modifying component. The composition may also be used for the treatment of obesity, elevated cholesterol, diabetes, hypertension or heart disease.